【GENETEC 0104 交流专区】震科

Hoga

Type	:	Announcement
Subject	:	GENETEC TECHNOLOGY BERHAD (“GENETEC”) PROPOSED BONUS ISSUE OF UP TO 127,890,000 NEW ORDINARY SHARES OF RM0.10 EACH IN GENETEC (“SHARES”) (“BONUS SHARES”) ON THE BASIS OF ONE (1) BONUS SHARE FOR EVERY ONE (1) EXISTING SHARE HELD AT A DATE TO BE DETERMINED AND ANNOUNCED LATER (“PROPOSED BONUS ISSUE”)
Contents	:	We refer to the announcements dated 12 March 2010 and 1 April 2010 in relation to the Proposed Bonus Issue. On behalf of the Board of Directors of Genetec, OSK Investment Bank Berhad (“OSK”) wishes to announce that Bursa Malaysia Securities Berhad (“Bursa Securities”) has, vide its letter dated 6 April 2010 (which was received on 7 April 2010 via fax), approved the listing of and quotation for up to 127,890,000 Bonus Shares.
Announcement Details : The approval granted by Bursa Securities in relation to the Proposed Bonus Issue is subject to the following conditions: (i) Genetec/OSK must fully comply with the relevant provisions under the ACE Market Listing Requirements

icy97

設計製造器材 震科獲1650萬合約

企業20/12/2011 22:00
（萬宜20日訊）震科（GENETEC，0104，創業板科技股）獲頒總值1650萬令吉合約，以為新舊客戶設計及製造器材。

該公司執行董事兼主席魯尼奧斯傑今日透過文告指出，是次合約主要客戶來自硬碟、汽車，及其他半導體領域。

“其中最大貢獻來自硬碟領域，佔總合約值的1310萬令吉，加上原有760萬令吉合約，硬碟領域訂單值達2070萬令吉，這也預示著硬碟領域已在復甦中。”

文告說，余下340萬令吉的合約來自汽車及其半導體領域，新合約可在2012財年貢獻震科營收。[ChinaPress]

icy97

SUMMARY OF KEY FINANCIAL INFORMATION

31/12/2011

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31/12/2011	31/12/2010	31/12/2011	31/12/2010
		$$'000	$$'000	$$'000	$$'000
1	Revenue	31,228	36,324	110,649	95,595
2	Profit/(loss) before tax	-4,026	4,975	-141	17,045
3	Profit/(loss) for the period	-4,051	3,206	-730	14,078
4	Profit/(loss) attributable to ordinary equity holders of the parent	-4,385	1,835	-1,508	11,314
5	Basic earnings/(loss) per share (Subunit)	-1.25	0.52	-0.43	3.80
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	1.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.1900		0.2100

icy97

獲2790萬計劃 震科訂單增至1億

企業23/03/2012 20:47
（吉隆坡23日訊）精密器材製造公司震科（GENETEC，0104，創業板科技股）獲得額外2790萬令吉計劃，使公司至今訂單達1億640萬令吉。

該公司今日發布文告指出，新獲得的訂單為器材和配備設計、生產與製造，設計的領域包括硬碟生產（2500萬令吉）、電子與代工生產（130萬令吉），及其他領域如食品和消費、汽車及藥物等（160萬令吉）。

這些訂單期限介于3個月至9個月，預計將推高公司截至2012年3月底至2013年3月底盈利。

該公司執行主席奧斯切在文告中指出，國際市場對硬碟需求增加，其中更要求具成本效率和更高儲存量的硬碟。

該公司截至2011年12月31日，接獲的訂單佔96%，達1億1060萬令吉。

文告指出，美國震科業務好轉，將可為公司帶來33%訂單。[ChinaPress]

icy97

SUMMARY OF KEY FINANCIAL INFORMATION

31/03/2012

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31/03/2012	31/03/2011	31/03/2012	31/03/2011
		$$'000	$$'000	$$'000	$$'000
1	Revenue	44,785	27,453	155,434	123,048
2	Profit/(loss) before tax	7,328	1,263	7,187	18,309
3	Profit/(loss) for the period	9,544	1,077	8,814	15,156
4	Profit/(loss) attributable to ordinary equity holders of the parent	5,556	1,106	4,048	12,420
5	Basic earnings/(loss) per share (Subunit)	1.58	0.31	1.15	4.17
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	1.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2100		0.2100

icy97

震科获4430万合约

财经新闻 财经  2012-05-31 12:23
（吉隆坡30日讯）震科（Genetec，0104，创业板）获得一份价值4430万令吉的合约，以设计与制造高科技精密工程设备。

文告显示，公司从现有客户以及新客户处获得新合约，客户分别来自汽车、硬盘驱动器以及其他领域。

震科披露，上述合约的期限是介于3至9个月，这取决于工程的规模。

公司预计，上述合约可为其截至2013年3月31日财年，带来盈利贡献，以及不会显著影响每股净资产。[Nanyang]

icy97

震科獲3690萬新訂單

企業財經14/06/2012 20:42
（吉隆坡14日訊）震科（GENETEC，0104，創業板科技股）向馬證交所報備，共接獲總值3690萬令吉新訂單。

該公司指出，公司將設計和製造高科技精密工程設備給這些現有和新客戶。

上述訂單，分別是來自汽車領域（800萬令吉）、硬碟（2810萬令吉），以及其他領域約80萬令吉的訂單。

該公司指出，這些訂單一般為期3至9個月，視規模和工程範圍而定。

震科看好，這些訂單將反映在公司截至明年3月底的財年業績上。[ChinaPress]

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30/06/2012

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30/06/2012	30/06/2011	30/06/2012	30/06/2011
		$$'000	$$'000	$$'000	$$'000

1	Revenue	47,465	39,520	47,465	39,520
2	Profit/(loss) before tax	629	2,003	629	2,003
3	Profit/(loss) for the period	446	1,430	446	1,430
4	Profit/(loss) attributable to ordinary equity holders of the parent	531	1,617	531	1,617
5	Basic earnings/(loss) per share (Subunit)	0.15	0.46	0.15	0.46
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2100		0.2100

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30/09/2012

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30/09/2012	30/09/2011	30/09/2012	30/09/2011
		$$'000	$$'000	$$'000	$$'000

1	Revenue	43,843	39,902	91,308	79,422
2	Profit/(loss) before tax	1,725	1,882	2,354	3,886
3	Profit/(loss) for the period	1,716	1,891	2,162	3,322
4	Profit/(loss) attributable to ordinary equity holders of the parent	1,786	1,260	2,318	2,878
5	Basic earnings/(loss) per share (Subunit)	0.51	0.36	0.66	0.82
6	Proposed/Declared dividend per share (Subunit)	0.00	1.00	0.00	1.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2100		0.2100

icy97

GENETEC TECHNOLOGY BERHAD

Type	Announcement
Subject	OTHERS
Description	NEW ORDERS SECURED BY GENETEC TECHNOLOGY BERHAD
Introduction Genetec Technology Berhad (“Genetec” or “the Company”) is pleased to announce that the Group has secured new orders worth RM22.6 million. The new orders require Genetec’s expertise in design and fabrication of high-tech precision engineering equipments. The orders were secured from the Group’s existing and new clients who are global players in the following industries: Industry Amount (RM Mil) 1 Hard Disk Drive 10.8 2 Semiconductor and OEM                 6.2 3 Others (i.e. Food and consumer, Electronic & etc.)                 5.6 Total 22.6 Directors’ and major shareholders’ interest None of the directors or major shareholders of Genetec, or any persons connected to them, has any direct or indirect interest in the above secured orders. Effects of the secured orders The secured orders are expected to contribute positively to Genetec’s earnings for the financial year ending 31 March 2013. The secured orders are not expected to have any material effect on the net assets per share of the Company for the financial year ending 31 March 2013. Additional information The tenure of the contracts normally range from three to nine months depending on the size of order and scope of work. The contracts are on project basis and we do not foresee any risk pertaining to new secured orders.

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31/12/2012

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31/12/2012	31/12/2011	31/12/2012	31/12/2011
		$$'000	$$'000	$$'000	$$'000

1	Revenue	46,700	31,228	138,008	110,649
2	Profit/(loss) before tax	-195	-4,026	2,159	-141
3	Profit/(loss) for the period	70	-4,051	2,232	-730
4	Profit/(loss) attributable to ordinary equity holders of the parent	1,585	-4,385	3,903	-1,508
5	Basic earnings/(loss) per share (Subunit)	0.45	-1.25	1.11	-0.43
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	1.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2200		0.2100

icy97

震科獲2230萬新訂單

大馬 即時大馬財經  2013-03-01 18:15
（吉隆坡1日訊）震科（GENETEC，0104，創業板科技組）宣佈，該公司取得總值2千230萬令吉的新訂單。

該公司文告指出，新合約範疇，主要是進行設計及組裝高科技精确工程器材，它們來自現有及新客戶，包括硬鍱驅動器領域（佔1千700萬令吉），汽車業（460萬令吉），以及其他（半導體，原莊配件製造及藥劑等領域則佔70萬令吉）。

上述新訂單完成期介於3個月至9個月。預料它對公司2013年及2014年財政年盈利作出正面貢獻。（星洲網）

GENETEC TECHNOLOGY BERHAD

Type	Announcement
Subject	OTHERS
Description	NEW ORDERS SECURED BY GENETEC TECHNOLOGY BERHAD
Introduction Genetec Technology Berhad (“Genetec” or “the Company”) is pleased to announce that the Group has secured new orders worth RM22.3 million. The new orders require Genetec’s expertise in design and fabrication of high-tech precision engineering equipments. The orders were secured from the Group’s existing and new clients who are global players in the following industries: Industry Amount (RM Mil) 1 Hard Disk Drive 17.0 2 Automotive               4.6 3 Others (i.e. semiconductor & OEM, pharmaceutical & etc.)               0.7 Total 22.3 Directors’ and major shareholders’ interest None of the directors or major shareholders of Genetec, or any persons connected to them, has any direct or indirect interest in the above secured orders. Effects of the secured orders The secured orders are expected to contribute positively to Genetec’s earnings for the financial year ending 31 March 2013 and 31 March 2014. The secured orders are not expected to have any material effect on the net assets per share of the Company for the financial year ending 31 March 2013 and 31 March 2014. Additional information The tenure of the contracts normally range from three to nine months depending on the size of order and scope of work. The contracts are on project basis and we do not foresee any risk pertaining to new secured orders. This announcement is dated 28 February 2013.

icy97

GENETEC TECHNOLOGY BERHAD

Type	Announcement
Subject	PRACTICE NOTE 1 / GUIDANCE NOTE 5 NEW DEFAULT
Description	GENETEC TECHNOLOGY BERHAD (“GENETEC” OR “COMPANY”) DEFAULT IN PAYMENT PURSUANT TO GUIDANCE NOTE 5 ("GN 5") OF THE ACE MARKET LISTING REQUIREMENTS OF BURSA MALAYSIA SECURITIES BERHAD (“AMLR”)
1.     Introduction Genetec wishes to inform that its indirect subsidiaries, namely Systems South, Inc., Genetec Technology Automation, Inc. and IP Systems, Inc. (all incorporated in the United States of America (“USA”)), all of which are directly held by its subsidiary, Genetec Global Technologies, Inc (Systems South, Inc., Genetec Technology Automation, Inc. and IP Systems, Inc. shall be referred to “USA subsidiaries”), have been notified vide the letters dated 28 March 2013 from Womble, Carlyle, Sandridge and Rice, acting for Wells Fargo Bank, National Association (“Wells Fargo”), of the default under the following loan/credit facilities granted by Wells Fargo which total outstanding amount is currently USD$1,786,504 (equivalent to RM5,538,163): (a)   Line of Credit of USD1.0 million granted to Systems South, Inc.; (b)  Line of Credit of USD1.0 million granted to Genetec Technology Automation, Inc.; and (c)   Line of Credit of USD2.6 million granted to IP Systems, Inc. 2.     Reason for the Default The USA subsidiaries have been incurring losses over the last 3 quarters of the financial year ended 31 March 2013 due to low volume of business amidst the continuous challenging economic and business climate in the USA. The loss making position has resulted in cash flow difficulties and constraints in theseUSA subsidiaries. 3.     Measures by Genetec to address the Default Genetec is in the process of negotiating and working out a repayment manner and schedule with Wells Fargo which includes expediting the realization of collaterals such as receivables and assets. In addition, Genetec is taking measures to mitigate and manage the challenges faced by the USA subsidiaries which include operational cost reduction involving a downsizing of the operations and workforce. 4.     Legal implications of the Default including the extent of Genetec’s liability in respect of the obligations incurred under the agreements for the indebtedness Pursuant to the Default, Wells Fargo has the right to enforce its rights under the loan documents which include enforcing the various collaterals given to secure the loan/credit facilities granted by Wells Fargo to the USA subsidiaries, which collateral includes the corporate guarantee given by Genetec. 5.     Business, financial and operational impact of the Default on the listed corporation The Default has no reasonably foreseeable material and adverse impact on the business, financial condition and operations of Genetec as the businesses and operations of the USA subsidiaries are managed independently from the Malaysian businesses and operations. 6.     In the event the Default is in respect of secured loan stocks or bonds, the lines of action available to the guarantors or security holders against the listed corporation Not Applicable. 7.     In the event the Default is in respect of payments under a debenture, to specify whether the Default will empower the debenture holder to appoint a receiver or receiver and manager Not Applicable. 8.     Whether the Default constitutes an event of default under a different agreement for indebtedness (cross default) and the details for such other default, where applicable If pursuant to the Default, a demand is made by Wells Fargo on Genetec under the corporate guarantee and Genetec fails to pay the guaranteed amount as demanded, such failure by  Genetec may trigger a cross default of other credit/loan facilities given to other companies within the Genetec group of companies, for which Genetec also stands as a guarantor or security party. As at the date of this announcement, Wells Fargo has not made a demand on Genetec as the corporate guarantor. 9.     Where the Default is in respect of a subsidiary or associated company, a confirmation as to whether the subsidiary or associated company is a major subsidiary or major associated company, as the case may be The USA companies are loss making entities and are therefore not major subsidiaries (as defined in the AMLR) of Genetec.   10.  Where the Default is in respect of a listed corporation, major subsidiary or major associated company, as the case may be - (i)    a statement as to whether the listed corporation is solvent (“Solvency Declaration”). For this purpose, a listed corporation is regarded as being “solvent” if the majority directors have formed the opinion that the listed corporation will be able to pay all its debts as and when they fall due within a period of 12 months from the date of the announcement; and (ii)  if the listed corporation is solvent, a statement that the listed corporation undertakes to provide to the Exchange, the Solvency Declaration duly executed by its board of directors within 3 market days from the announcement date Not applicable as the Default is not in respect of Genetec or a major subsidiary of Genetec. This announcement is dated 2 April 2013.

icy97

GENETEC TECHNOLOGY BERHAD

Type	Announcement
Subject	PRACTICE NOTE 1 / GUIDANCE NOTE 5 OTHERS
Description	GENETEC TECHNOLOGY BERHAD (''GENETEC'' OR ''COMPANY'') DEFAULT IN PAYMENT PURSUANT TO GUIDANCE NOTE 5 (“GN5”) OF THE ACE MARKET LISTING REQUIREMENTS OF BURSA MALAYSIA SECURITIES BERHAD (“AMLR”)
Reference is made to Genetec’s announcement dated 2 April 2013 in relation to the default in payment pursuant to Guidance Note 5 (“GN5”) of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad (“AMLR”). We wish to furnish the following additional information relating to the default in payment:- 1.             Date of Default   The default was notified to us in writing vide the letters dated 28 March 2013 from Womble, Carlyle, Sandridge and Rice, acting for the bank. 2.             Date of Receipt of the Letter of Default       29 March 2013 This announcement is dated 4 April 2013.

icy97

震科獲3110萬合約

大馬 即時大馬財經  2013-05-23 13:51
（吉隆坡23日訊）震科（GENETEC，0104，創業板科技組）宣佈獲取價值3千110萬令吉新合約。

該公司發表文告指出，新約合來自現有客戶，包括硬碟、汽車及其它領域，如半導體代工、藥物等國際業者，合約期限為期3至9個月，料正面貢獻截至2014年3月31日止財政年業績。（星洲網）

GENETEC TECHNOLOGY BERHAD

Type	Announcement
Subject	OTHERS
Description	NEW ORDERS SECURED BY GENETEC TECHNOLOGY BERHAD
Introduction Genetec Technology Berhad (“Genetec” or “the Company”) is pleased to announce that the Group has secured new orders worth RM31.1 million. The new secured orders are from the existing clients who are global players in the following industries: Industry Amount (RM Mil) 1 Hard Disk Drive 25.2 2 Automotive   3.6 3 Others (i.e. semiconductor & OEM, pharmaceutical & etc.)   2.3 Total 31.1 Directors’ and major shareholders’ interest None of the directors or major shareholders of Genetec, or any persons connected to them, has any direct or indirect interest in the above secured orders. Effects of the secured orders The secured orders are expected to contribute positively to Genetec’s earnings for the financial year ending 31 March 2014. The secured orders are not expected to have any material effect on the net assets per share of the Company for the financial year ending 31 March 2014. Additional information The tenure of the contracts normally range from three to nine months depending on the size of order and scope of work. The contracts are on project basis and we do not foresee any risk pertaining to new secured orders. This announcement is dated 22 May 2013.

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31/03/2013

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31/03/2013	31/03/2012	31/03/2013	31/03/2012
		$$'000	$$'000	$$'000	$$'000

1	Revenue	14,488	30,475	123,112	123,038
2	Profit/(loss) before tax	-19,122	2,132	-8,105	8,348
3	Profit/(loss) for the period	-34,273	9,544	-32,039	8,814
4	Profit/(loss) attributable to ordinary equity holders of the parent	-29,769	5,556	-25,866	4,048
5	Basic earnings/(loss) per share (Subunit)	-8.46	1.58	-7.35	1.15
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	1.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.1300		0.2100

icy97

GENETEC TECHNOLOGY BERHAD

Type	Announcement
Subject	PRACTICE NOTE 1 / GUIDANCE NOTE 5 MONTHLY ANNOUNCEMENT
Description	GENETEC TECHNOLOGY BERHAD (“GENETEC” OR “COMPANY”) MONTHLY UPDATES ON THE STATUS OF ITS DEFAULT IN PAYMENT PURSUANT TO GUIDANCE NOTE 5 OF THE ACE MARKET LISTING REQUIREMENTS OF BURSA MALAYSIA SECURITIES BERHAD (“GN5”)
We refer to our earlier announcement on 2 April 2013, 4 April 2013, 2 May 2013 and 31 May 2013 and in compliance with paragraph 3.2 (a) of GN 5. The Board of Directors of Genetec wishes to announce that Phoenix Management Services, LLC of Atlanta, USA is still in the progress to recover the assets from the collection of the outstanding account receivables in Systems South Inc, an indirect subsidiary of Genetec. As at to-date, the outstanding amount owing to Wells Fargo Bank, National Association (“Wells Fargo”) has reduced from USD1,553,000 (RM4,814,300) to USD1,313,000 (RM4,070,300) after repayment of USD240,000 (RM744,000) to Wells Fargo arising from the disposal of assets and repayment from IP Systems, Inc, one of our indirect subsidiary in USA. Further announcement on the development of the above matter will be made to Bursa Malaysia Securities Berhad in the due course. This announcement is dated 1 July 2013.

icy97

GENETEC TECHNOLOGY BERHAD

Type	Announcement
Subject	OTHERS
Description	GENETEC TECHNOLOGY BERHAD (''GENETEC'' OR THE ''COMPANY'') - LETTER OF INTENT FOR THE PROPOSED DISPOSAL OF CERTAIN ASSETS OF IP SYSTEMS, INC.
The Board of Genetec (“Board”) wishes to inform that the Company and its 60%-owned indirect subsidiary, namely IP Systems, Inc (“IPS”), incorporated in the United States of America (“USA”), which is directly held by Genetec Global Technologies, Inc. (“GGT”), a wholly-owned subsidiary of Genetec, has on 18 July 2013 signed a Letter of Intent from Springs Fabrication, Inc. (“SFI”) (“Purchaser”) expressing SFI’s intention to acquire certain assets and operations of IPS (“Subject Assets”) from IPS and, to the extent necessary, such shareholders of IPS (“Sellers”) for an aggregate cash consideration of USD 200,000.00 only or approximately RM620,000.00 only (based on an exchange rate of RM3.10 for every USD1.00) (“Disposal Price”) (“Proposed Disposal”) (“LOI”). This announcement is dated 18 July 2013.

Attachments LOI For The Proposed Disposal of Certain Assets of IPS.pdf

icy97

GENETEC TECHNOLOGY BERHAD

Type	Announcement
Subject	PRACTICE NOTE 1 / GUIDANCE NOTE 5 MONTHLY ANNOUNCEMENT
Description	GENETEC TECHNOLOGY BERHAD (“GENETEC” OR “COMPANY”) MONTHLY UPDATES ON THE STATUS OF ITS DEFAULT IN PAYMENT PURSUANT TO GUIDANCE NOTE 5 OF THE ACE MARKET LISTING REQUIREMENTS OF BURSA MALAYSIA SECURITIES BERHAD (“GN5”)
We refer to our earlier announcement on 2 April 2013, 4 April 2013, 2 May 2013, 31 May 2013 and 1 July 2013 and in compliance with paragraph 3.2 (a) of GN 5. The Board of Directors of Genetec wishes to announce that Phoenix Management Services, LLC of Atlanta, USA is still in the progress to recover the assets from the collection of the outstanding account receivables in Systems South Inc, an indirect subsidiary of Genetec. As at to-date, the outstanding amount owing to Wells Fargo Bank, National Association (“Wells Fargo”) has reduced from USD1,313,000 (RM4,070,300) to USD1,263,000 (RM3,915,300) after repayment of USD50,000 (RM155,000) to Wells Fargo from Genetec. Further announcement on the development of the above matter will be made to Bursa Malaysia Securities Berhad in the due course. This announcement is dated 1 August 2013.

icy97

震科獲1210萬新合約

財經14 Aug 2013 21:54
（吉隆坡14日訊）震科（GENETEC，0104，創業板科技股）獲得來自不同領域頒發的新合約，總值1210萬令吉。

該公司向馬證交所報備指出，新合約全都來自現有的國際客戶。

上述客戶分別來自硬碟（HDD）領域，共發出830萬令吉合約、汽車業發出170萬令吉合約及其他領域（如半導體、藥劑、代工生產等）共發出210萬令吉，總計1210萬令吉。

震科預計，上述新合約一般期限介于3至9個月，胥視合約規模，但上述合約料將貢獻公司截至2014財年3月底的財報。[中国报财经]

GENETEC TECHNOLOGY BERHAD

Type	Announcement
Subject	OTHERS
Description	NEW ORDERS SECURED BY GENETEC TECHNOLOGY BERHAD
Introduction Genetec Technology Berhad (“Genetec” or “the Company”) is pleased to announce that the Group has secured new orders worth RM12.1 million. The new secured orders are from the existing clients who are global players in the following industries: Industry Amount (RM Mil) 1 Hard Disk Drive 8.3 2 Automotive 1.7 3 Others (i.e. semiconductor & OEM, pharmaceutical & etc.) 2.1 Total 12.1 Directors’ and major shareholders’ interest None of the directors or major shareholders of Genetec, or any persons connected to them, has any direct or indirect interest in the above secured orders. Effects of the secured orders The secured orders are expected to contribute positively to Genetec’s earnings for the financial year ending 31 March 2014. The secured orders are not expected to have any material effect on the net assets per share of the Company for the financial year ending 31 March 2014. Additional information The tenure of the contracts normally range from three to nine months depending on the size of order and scope of work. The contracts are on project basis and we do not foresee any risk pertaining to new secured orders. This announcement is dated 14 August 2013.